Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001829126-24-007586
Filing Date
2024-11-15
Accepted
2024-11-15 16:10:27
Documents
63
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q opgeninc_10q.htm   iXBRL 10-Q 1348244
2 EXHIBIT 31.1 opgeninc_ex31-1.htm EX-31.1 16259
3 EXHIBIT 31.2 opgeninc_ex31-2.htm EX-31.2 10797
4 EXHIBIT 32.1 opgeninc_ex32-1.htm EX-32.1 10486
  Complete submission text file 0001829126-24-007586.txt   6775212

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE opgn-20240930.xsd EX-101.SCH 57258
6 XBRL CALCULATION FILE opgn-20240930_cal.xml EX-101.CAL 57772
7 XBRL DEFINITION FILE opgn-20240930_def.xml EX-101.DEF 237951
8 XBRL LABEL FILE opgn-20240930_lab.xml EX-101.LAB 406593
9 XBRL PRESENTATION FILE opgn-20240930_pre.xml EX-101.PRE 350961
65 EXTRACTED XBRL INSTANCE DOCUMENT opgeninc_10q_htm.xml XML 1024523
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 301-869-9683
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

EIN.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37367 | Film No.: 241467941
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)